4D PHARMA PLC — TTAB Proceedings

4D PHARMA PLC is a party to 2 TTAB proceedings.

Proceedings

Proceeding 92081350 — Cancellations, Terminated (filed 2023-01-12) against 4D Molecular Therapeutics Inc. as defendant
Proceeding 87732684 — Extensions of Time to Oppose, Terminated (filed 2018-06-20) against Caris MPI, Inc. as plaintiff

2023-04-13: 92081350 — TERMINATED involving 4D Molecular Therapeutics Inc.
2023-04-13: 92081350 — COMMR ORDER CANCELLING REG involving 4D Molecular Therapeutics Inc.
2023-04-12: 92081350 — BOARD'S DECISION: GRANTED involving 4D Molecular Therapeutics Inc.
2023-03-03: 92081350 — NOTICE OF DEFAULT involving 4D Molecular Therapeutics Inc.
2023-01-12: 92081350 — PENDING, INSTITUTED involving 4D Molecular Therapeutics Inc.
2023-01-12: 92081350 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving 4D Molecular Therapeutics Inc.
2023-01-12: 92081350 — FILED AND FEE involving 4D Molecular Therapeutics Inc.
2018-09-18: 87732684 — EXTENSION OF TIME GRANTED involving Caris MPI, Inc.
2018-09-18: 87732684 — FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Caris MPI, Inc.
2018-06-20: 87732684 — EXTENSION OF TIME GRANTED involving Caris MPI, Inc.
2018-06-20: 87732684 — INCOMING - EXT TIME TO OPPOSE FILED involving Caris MPI, Inc.